Intracerebral hemorhage Diagnosis and managementRamesh Babu
About ICH - Diagnosis and management, Discussed the clinical presentation, evaluation, radiological features and management including recent guidelines
Due to stretching forces placed on individual nerve cells
Pathology distributed throughout brain
Types
Concussion
Diffuse Axonal Injury (Moderate to Severe)
Acute stroke management
IV thrombolysis guidelines
IV thrombolysis side effects
Early CT changes in stroke
ASPECTS scoring
AHA stroke guidelines
Thrombolysis controversies
Intracerebral hemorhage Diagnosis and managementRamesh Babu
About ICH - Diagnosis and management, Discussed the clinical presentation, evaluation, radiological features and management including recent guidelines
Due to stretching forces placed on individual nerve cells
Pathology distributed throughout brain
Types
Concussion
Diffuse Axonal Injury (Moderate to Severe)
Acute stroke management
IV thrombolysis guidelines
IV thrombolysis side effects
Early CT changes in stroke
ASPECTS scoring
AHA stroke guidelines
Thrombolysis controversies
PPT on all important trials of traumatic brain injury. - includes design, setting, statistical analysis,outcome, strength, limitations, conclusion#DECRA#RESCUEicp#BEST TRIP#CRASH1#CRASH3#SAFE TBI#EUROTHERM3939#POLAR TRIAL
Also includes trial related BTF guidelines
Survival after cardiac arrest is poor but some therapies can make a difference. This presentation discusses the evidence for therpauetic hypothermia, normoxia, management of blood pressure and early cardiac catherterisation. It also makes the case that these might be elements of a bundle of care.
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...Premier Publishers
Reperfusion therapy is the cornerstone in management of STEMI. This study was designed to evaluate both In-hospital and 30 days outcome in patients with STEMI treated with primary percutaneous coronary intervention (PPCI) versus fibrinolysis. This prospective, controlled, study included 140 patients with STEMI who were eligible for reperfusion therapy. In hospital and 30 days major adverse cardiovascular events (MACE) were reported and head to head comparison was done between PPCI versus fibrinolysis. All-cause mortality was reported in 5% of patients (10% versus 0% in fibrinolysis and PPCI respectively, p=0.07), recurrence of ischemic symptoms was reported in 18% of patients (30% versus 7% in fibrinolysis and PPCI respectively, P =0.02), heart failure was evident in 22% of patients (33% versus 10% in fibrinolysis and PPCI respectively, P =0.02). PPCI is safe and effective treatment option for patients with STEMI
Trial of decompressive craniectomy for traumatic intracranial hypertension1Dr fakhir Raza
The New England Journal of Medicine, Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension, Extended Glasgow Outcome Scale (GOS-E), vegetative state, lower severe disability, traumatic brain injury, RESCUEicp,
Neuroimaging Mastery Project Presentation #4: Acute Epidural HematomasSean M. Fox
Drs. Faith Meyers, Madison Watts and Steven Perry are Emergency Medicine Residents at Carolinas Medical Center who are interested in medical education. Along with the guidance of Dr. Michael Gibbs (Chair of Emergency Medicine), Dr. Jonathan Clemente (Chief of the Department of Radiology and Neuroradiology specialist), Dr. Christa Swisher (Neurocritcal Care Intensivist), and Dr. Scott Wait (Chief of Pediatric Neurosurgery) they aim to help educate us on Neuroimaging. In this presentation they will address Atraumatic Neurosurgical Intracranial Infections. Follow along with the EMGuideWire.com team as they post the CMC Neuroimaging Case Studies.
- Acute Epidural Hematomas
A thorough look at the pitfalls of Evidence Based Medicine to bear in mind when you read a journal publication - though respect to medical researchers for their efforts to find "the truth" systamatically
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
2. Where to start??
• Intracranial hemorrhage (MeSH term) + 2010
– 2014 = 4839
• Review articles only = 246
• Each type of bleed – last 5 years on PubMed
www.theneurosim.com
3. Types of Haemorrhage
• EDH – 1 - 4% of TBI up to 15% post mortem series
• SDH – Acute (up to 72hrs) – 30% severe TBI and
chronic (2-3 weeks) 7.35% of 70-79yr olds
• ICH – 24.6/100,000 – 1 month mortality 40%.
Only 12-39% live independently. Best outcomes =
Japan
• SAH – 10-15/100,000 higher Finland/Japan lower
China. 50% die, 30% survivors remain dependent
www.theneurosim.com
5. EDH
• 30 cm3 = Surgical Evacuation
• <30cm3 + <5cm midline shift + < 15mm
thickest part AND GCS > 8 with NO FOCAL
DEFICIT = serial CT + observe in Neurosurgical
unit
– BTF Guidelines http://tbiguidelines.org/glHome.aspx?gl=3
www.theneurosim.com
6. • Extradural haematoma—To evacuate or not?
Revisiting treatment guidelines Z. Zakaria et al.
Clinical Neurology and Neurosurgery 115 (2013)
1201–1205
– 3 cases
– 2 large (>30cm3) EDH’s managed conservatively = good
outcomes
– 1 large EDH surgically evacuated = poor outcome
– Excellent summary of current literature on EDH and
existing controversies
www.theneurosim.com
7. 28yr old. Fall. CT scan showed a large EDH in the right parieto-occipital region with a
MLS of 5mm(Fig. 1a). Small temporal contusions were also noted on the scan. The
blood volume was 90cm3. He was admitted for neurologic observation and
analgesics were administered. After a few hours, his symptoms receded, and 24 h
later he remained well. A repeat CT scan showed no change in the features of the
EDH. www.theneurosim.com
9. www.theneurosim.com
52 man. Collapse. GCS 14/15 then 6/15. 130cm3 Rt EDH clot with 1mm shift
evacuated. Dense Rt hemiplegia with GCS 13/15 outcome = Kernahon’s Notch
phenomenon.
10. Acute SDH
• >10mm thick or >5mm shift = surgical
evacuation regardless of GCS
• <10mm thick + <5mm shift operate if GCS <9
AND/OR:
– GCS drop by 2 between injury + admission
– Pupils fixed dilated
– ICP >20
– BTF Guidelines: http://tbiguidelines.org/glHome.aspx?gl=3
www.theneurosim.com
11. SDH
• Mortality uncomplicated ASDH = 20% but up
to 50% and even 70% in some studies (Taussky et al 2008)
• Why so bad?
www.theneurosim.com
GOS 4 + 5
GOS 3
GOS 1 + 2
anisocore
areactive
anisocore
reactive
isocore
reactive
100%
80%
60%
40%
20%
0%
Pupil
reactivity on
initial
assessment
(Taussky et al
2008)
Age and
initial GCS
also
predict
outcome
12. Decompressive Craniectomy
• Depends on how you class a “favourable”
outcome:
– Ischaemic stroke- improves survival BUT analysis of
European Stroke Trials classed modified Rankin Score
4 as favourable (Vahedi et al Lancet 2007)
– Meta analysis increases chance survival with
unfavourable outcome
– TBI – No evidence increased chance of survival with
favourable or unfavourable outcome – studies are
heterogenous (Honeybul & Ho 2013)
– DECRA – early DC for ICP > 20 for 15mins. Outcomes
worse in surgical arm @6/12
– Also has high morbidity/ complication rate
www.theneurosim.com
14. CSDH
• Mortality around 13%
• Craniostomy (Burr holes) 1st line mx +
morbidity higher in craniotomy
• Drain = less recurrence (Weigel et 2003)
• 2 Burr holes better than 1 – less infection +
shorter hospital stay (Smith et al 2012)
• Significant correlation exists between initial
GCS and GOS after burr hole (Amirjamshidi et al 2007)
www.theneurosim.com
15. CSDH > 90yrs
• 2 recent papers:
• Stippler et al 2013. 21 pts >90yrs. 16 (76%) =
surgery (craniotomy or burr hole) 5 were
observed. Surgical group =31% died. 31%
nursing home. 13% rehab. 24% home
• Tabuchia et al 2014. 20 pts >90yrs. 12 (60%)
burr hole under LA – rest conservative.
Surgical group = 0 deaths. 66.7% home
www.theneurosim.com
16. SAH Stroke. 2009;40:0-0
• If it has bled – secure it (Class I, Level of Evidence B).
• Do it early (Class IIa, Level of Evidence B) – and in a centre
where it’s done a lot (Class IIa, Level of Evidence B).
• If it’s amenable to coil or clip – coil it (Class I, Level of
Evidence B) ISAT showed endovascular coiling is associated
with better outcomes at 1 year than surgical clipping if both
surgeon and radiologist equally experienced
• Anaesthetists – minimise hypotension during securing(Class
IIa, Level of Evidence B).
• For Vasospasm – Nimodipine (Class I, Level of Evidence A).
Normovolaemia (Class IIa, Level of Evidence B). Triple H
therapy (Class IIa, Level of Evidence B). Angioplasty or
intraluminal vasodilators (Class IIb, Level of Evidence B).
www.theneurosim.com
17. • Subarachnoid hemorrhage: an update for the
intensivist. A. Coppadoro, G. Citerio. Minerva
Anestesiol 2011;77:74-84
– After five years, relative risk of death is less for patients
who have undergone coiling treatment, but no difference
is demonstrated in the probability of good neurological
status
– Risk of reintervention with coiling is higher than clipping
– Conversely, risk of rebleeding at eight years does not
appear to be dependent on the type of treatment
– Expert Committee of the American Academy of Neurology
supports the use of TCD on the basis that severe spasms
can be identified with fairly high reliability.
– Emerging evidence shows CT perfusion (CTP) as the
imaging technique of choice for early assessment of
vasospasms. Unlike TCD it is predictive of secondary
cerebral infarction
www.theneurosim.com
18. • vasopressor-induced elevation of mean arterial
pressure causes a significant increase in regional
cerebral blood flow and brain tissue oxygenation
whereas volume expansion only slightly increased flow
and reversed the positive effect on tissue oxygenation
• Clazosentan, an endothelin receptor antagonist.
showed a dose-dependent reduction in angiographic
vasospasms in comparison with a placebo in a recent
RCT of 413 patients but is NOT SIGNIFICANT
(CONSCIOUS 2)
• MASH 2 trial magnesium treatment decreased the
occurrence of DCI and poor outcome but MASH 3
(phase 3 trial + metanalysis) showed no reduction in
poor outcome
www.theneurosim.com
19. • Effect of different components of triple-H
therapy on cerebral perfusion in patients with
aneurysmal subarachnoid haemorrhage: a
systematic review. Dankbaar et al. Critical Care
2010, 14:R23
– There is no good evidence from controlled studies
for a positive effect of triple-H or its separate
components on CBF in SAH patients. In
uncontrolled studies, hypertension seems to be
more effective in increasing CBF than
hemodilution or hypervolemia
www.theneurosim.com
20. www.theneurosim.com
• Subarachnoid hemorrhage from intracranial aneurysms
during pregnancy and the puerperium. Kataoka H et al.
Neurol Med Chir (Tokyo). 2013;53(8):549-54
• > 50% IA ruptures occur in third trimester
• Both mother and foetus benefit from surgery –
maternal mortality in surgical group 11% vs 63% in
non-surgical and foetal mortality is 5% vs 27%
• If gestation >28 weeks – c-section and clipping. If not –
clip whilst maintain pregnancy
• If ICP high – clot evac and EVD whilst foetal monitoring.
If foetal distress – suspend ICP procedure and c-section
• Coiling – radiation absorption is low but heparinization
and re-bleed risk is greater – so clipping better – but
not unsafe (Endovascular treatment in pregnancy.
Neurol Med Chir (Tokyo). 2013;53(8):541-8 for an
excellent summary)
21. ICH Stroke.2010;41:2108-2129
• Rapid Imaging (Class I; Level of Evidence: A).
• Control the BP if >>150 = aim for 140 (Class IIa; Level of
Evidence: B).
• Correct their INR (Class I; Level of Evidence: C)
• PCCs have not shown improved outcome compared
with FFP but less side effects so reasonable alternative.
rfVII alone not recommended for OAC reversal
• Monitor + manage in ICU (Class I; Level of Evidence: B).
• Although theoretically attractive, no clear evidence at
present indicates that ultra-early removal of
supratentorial ICH improves functional outcome or
mortality rate. Very early craniotomy may be harmful
due to increased risk of recurrent bleeding (Class III;
Level of Evidence: B)
www.theneurosim.com
22. • Surgery for Intracerebral Hemorrhage Moving Forward
or Making Circles? Flaherty & Beck.
Stroke.2013;44:2953-2954.
• 2 basic rationales for surgical removal of blood after.
ICH.
– to reduce mass effect, to improve intracranial pressure and brain
perfusion and to prevent dangerous compartment shifts and
herniation
– removal of blood products may reduce secondary injury caused by
blood breakdown and adverse biochemical or inflammatory processes
– STICH I, published in 2005, remains the largest trial (with a sample size
of 1033 subjects) to test this hypothesis) no benefit in 6-month
favorable outcome in the surgical group (26%) compared with the
medical group (24%, P=0.41
– subjects with lobar ICH ≤1 cm from the brain surface who underwent
surgery had an 8% absolute increase in good outcomes
– STICH II – 607 patients - primary outcome of the trial, measured as
favorable outcome on the Extended Glasgow Outcome Scale, did not
reach statistical significance
www.theneurosim.com
23. • a subgroup analysis on the effect of baseline prognosis (poor versus
good) identified an interaction, such that subjects in the poor
prognosis group randomized to surgery were more likely to have a
favorable outcome than those randomized to medical care
• Subjects who were judged in need of surgery were not enrolled.
• 26% of subjects randomized to medical management ultimately
crossed over to surgery. In STICH II, 21% of subjects crossed over to
surgery. These subjects were typically sicker, with lower GCS scores
and larger hematomas.
• If none of these patients had undergone surgery, the rates of poor
outcome and death in the medical group may have been higher
• minimally invasive hematoma drainage assisted by tissue
plasminogen activator infusion; the Minimally Invasive Surgery plus
rtPA for Intracerebral Hemorrhage Evacuation (MISTIE) I and MISTIE
II trials have been completed, and a phase III trial is being organized
www.theneurosim.com
24. • MISTIE II trial = clot lysis through infusion rtPA
via burr hole showed improved outcomes past
180 days vs medical mx. 8% rtPa group to
Nhome vs 21% of medical mx and35% shorter
hospital stay in rtPA ,
• Phase 3 trial onging
www.theneurosim.com
25. • Long-term prognosis after intracerebral haemorrhage:
systematic review and meta-analysis. Poon MTC, et al. J
Neurol Neurosurg Psychiatry 2014;85:660–667
– This systematic review and meta-analysis (>30 days)
outcome after spontaneous ‘primary’ ICH = 1-year survival
was 46.0% and 5-year survival was 29.2%
– predictors of death in the long term were increasing age,
decreasing Glasgow Coma Scale score, increasing ICH
volume, presence of intraventricular haemorrhage and
deep/infratentorial ICH location, which are the principal
components of the ICH score
– Less than a half of patients with ICH survive 1 year and less
than a third survive 5 years. Risks of recurrent ICH and
ischaemic stroke after ICH appear similar after ICH,
provoking uncertainties about the use of antithrombotic
drugs.
www.theneurosim.com
26. In Sum
• If you are going to bang your head, have an EDH not an ASDH
• If you’re over 65 with an ASDH your chance of being able to look after yourself without
help is about 40% (but that’s only if you’re not in the 35% who die perioperatively)
• So have your clot evacuated and your Warfarin reversed
• If you have a CSDH and are over 90 years old, have it in Tokyo not New Mexico
• Being a girl is still a slightly risky business for SAH - especially if you smoke, drink and
have high blood pressure
• Have your aneurysm coiled if possible (unless you’ve had a subdural – then have it
clipped whilst you have your clot evacuated) and your vasospasm treated with
hypertension – not lots of fluids
• And if you’re pregnant try to have your SAH after 28 weeks so baby can be delivered – if
not clipping provides the better occlusion – but whichever you choose – have your
aneurysm secured
• Try not to have an haemorrhagic stroke – and certainly not one with a spot sign on
contrast CT
• If you do then have your clot evacuated if your prognosis is poor or if it’s in your post
fossa
• If your prognosis isn’t so awful – have some rTPA lysis rather than a craniotomy whilst you
have your BP controlled
• And overall be managed in a centre that has experience at dealing with these things
(preferably in Tokyo!!)
www.theneurosim.com
27. • Outcome of contemporary surgery for chronic subdural haematoma: evidence
based review. R Weigel, P Schmiedek, and J Krauss. J Neurol Neurosurg Psychiatry.
2003 Jul; 74(7): 937–943
• Surgical management of chronic subdural haematoma: one hole or two? Smith
MD1, Kishikova L, Norris JM. Int J Surg. 2012;10(9):450-2.
• Outcome after acute traumatic subdural and epidural haematoma in Switzerland:
a single-centre experience. Taussky P1, Widmer HR, Takala J, Fandino J.
SWISS MED WKLY 20 08;138(19–20):281–285
• The current role of decompressive craniectomy in the management of neurological
emergencies. S. Honeybul, & K. M. Ho. Brain Inj, 2013; 27(9): 979–991
• Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised
placebo-controlled trial . Sanne M Dorhout Mees,a,* Ale Algra,a,b W Peter
Vandertop,d Fop van Kooten,e Hans AJM Kuijsten,f Jelis Boiten,g Robert J van
Oostenbrugge,h Rustam Al-Shahi Salman,i Pablo M Lavados,j Gabriel JE Rinkel,a and
Walter M van den Berghc Lancet. 2012 Jul 7; 380(9836): 44–49.
www.theneurosim.com
28. • Age and Salvageability: Analysis of Outcome of Patients Older than 65 Years
Undergoing Craniotomy for Acute Traumatic Subdural Hematoma. Taussky,
et al WORLD NEUROSURGERY, DOI:10.1016/j.wneu.2011.10.030
• Aneurysmal acute subdural hemorrhage: Prognostic factors associated with
treatment. Kulwin et al. Journal of Clinical Neuroscience 21 (2014) 1333–
1336
• The current role of decompressive craniectomy in the management of
neurological emergencies. Honeybul. Brain Inj, 2013; 27(9): 979–991
• Extradural haematoma—To evacuate or not? Revisiting treatment
guidelines. Zakaria et al. Clinical Neurology and Neurosurgery 115 (2013)
1201–1205
• Glasgow Coma Scale on admission is correlated with postoperative Glasgow
Outcome Scale in chronic subdural hematoma. Amirjamshidi et al. Journal of
Clinical Neuroscience 14 (2007) 1240–1241
• Advances in the management of intracerebral hemorrhage. Kuramatsu et al.
J Neural Transm (2013) 120:S35–S41
• Neuroimaging in Intracerebral Hemorrhage. Macellari et al. Stroke.
2014;45:903-908.)
www.theneurosim.com
29. • Outcome of acute and chronic subdural hematomas in patient 90 years
and older. Stippler et al, 3.cns.org/dp/2012CNS/419.pdf
• Outcome after acute traumatic subdural and epidural haematoma in
Switzerland: a single-centre experience. Taussky et al, SWISS MED WKLY
20 08;138(19–20):281–285
• Subarachnoid Haemorrhage from Intracranial Aneurysms during
Pregnancy and the Peurperium. Kataoka et al, Neurol Med Chir (Tokyo)
53,549-554. 2013
• Surgery for Intracerebral Hemorrhage Moving Forward or Making Circles?
Flaherty. Stroke. 2013;44:2953-2954.
• Traumatic brain injury: intensive care management. Helmy et al. Br J
Anaesth 2007; 99: 32–42
• Chronic Subdural Hematoma in Patients Over 90 Years Old in a Super-Aged
Society. Tabuchi. J Clin Med Res. 2014;6(5):379-383
• Effect of different components of triple-H therapy on cerebral perfusion in
patients with aneurysmal subarachnoid haemorrhage: a systematic
review. Dankbaar et al. Critical Care 2010, 14:R23
• Long-term prognosis after intracerebral haemorrhage: systematic review
and meta-analysis. Poon MTC, et al. J Neurol Neurosurg Psychiatry
2014;85:660–667
• New Developments in the Treatment of Intracerebral Hemorrhage.
Gomes. Neurol Clin 31 (2013) 721–735
www.theneurosim.com